Diabetologia · 2021 · 13 citations · 35 references
MedicineEndocrinologyPharmacologyMetabolic RegulationNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyDiabetes MellitusInsulin ResistanceMetabolic SyndromePancreatic EndocrinologyBeta Cell BiologyBeta-cell DysfunctionGlucose-dependent Insulin SecretionGlucose-stimulated Insulin SecretionInsulin MetabolismPancreatic Islet FunctionPancreatic SecretionSerotonergic System Effects
Abstract Aims/hypothesis Second-generation antipsychotic (SGA) drugs have been associated with the development of type 2 diabetes and the metabolic syndrome in patients with schizophrenia. In this study, we aimed to investigate the effects of two different SGA drugs, olanzapine and aripiprazole, on metabolic state and islet function and plasticity. Methods We analysed the functional adaptation of beta cells in 12-week-old B6;129 female mice fed an olanzapine- or aripiprazole-supplemented diet (5.5–6.0 mg kg −1 day −1 ) for 6 months. Glucose and insulin tolerance tests, in vivo glucose-stimulated insulin secretion and indirect calorimetry were performed at the end of the study. The effects of SGAs on beta cell plasticity and islet serotonin levels were assessed by transcriptomic analysis and immunofluorescence. Insulin secretion was assessed by static incubations and Ca 2+ fluxes by imaging techniques. Results Treatment of female mice with olanzapine or aripiprazole for 6 months induced weight gain ( p <0.01 and p <0.05, respectively), glucose intolerance ( p <0.01) and impaired insulin secretion ( p <0.05) vs mice fed a control chow diet. Aripiprazole, but not olanzapine, induced serotonin production in beta cells vs controls, likely by increasing tryptophan hydroxylase 1 (TPH1) expression, and inhibited Ca 2+ flux. Of note, aripiprazole increased beta cell size ( p <0.05) and mass ( p <0.01) vs mice fed a control chow diet, along with activation of mechanistic target of rapamycin complex 1 (mTORC1)/S6 signalling, without preventing beta cell dysfunction. Conclusions/interpretation Both SGAs induced weight gain and beta cell dysfunction, leading to glucose intolerance; however, aripiprazole had a more potent effect in terms of metabolic alterations, which was likely a result of its ability to modulate the serotonergic system. The deleterious metabolic effects of SGAs on islet function should be considered while treating patients as these drugs may increase the risk for development of the metabolic syndrome and diabetes. Graphical abstract
35
Near-optimal probabilistic RNA-seq quantification
Nicolas Bray, Harold Pimentel, Páll Melsted et al. · Nature Biotechnology · 2016 · 11K citations · Full text
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao, Jing Wang, Eric J. Jaehnig et al. · Nucleic Acids Research · 2019 · 3.5K citations · Full text
Serotonin regulates pancreatic beta cell mass during pregnancy
Hail Kim, Yukiko Toyofuku, Francis C. Lynn et al. · Nature Medicine · 2010 · 583 citations · Full text